Chinook Therapeutics Inc Cvr (ADRO)
EBITDA Margin
-362.03%
Quarterly · Period ending:
ADRO EBITDA Margin
Latest reported-362.03%period ending
Latest reported-362.03%period ending
ADRO Quarterly EBITDA Margin (-25548.00% → -362.03%)
Quarterly ebitda margin
High-resolution chart · PNG
ADRO ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -362.028% | |
| -280.5167% | |
| -86.81% | |
| -504.2389% | |
| -458.0329% | |
| -355.7079% | |
| -564.6013% | |
| -921.5736% | |
| -727.9465% | |
| -878.6662% | |
| -306.0963% | |
| -693.7433% | |
| -721.165% | |
| -375.5112% | |
| -625.8218% | |
| -607.607% | |
| -599.6837% | |
| 11.0059% | |
| -623.0025% | |
| 9.7248% | |
| 3.8076% | |
| -264.4339% | |
| -172.582% | |
| -185.6798% | |
| -261.8274% | |
| -25,548% |